Abstract
A 23-year-old woman presents for her initial obstetric visit at 9 weeks gestation with chief concern of 1-week- Fig. 1A) [6] . 13 % of pregnant women showed seroprevalence for both HSV-1 and HSV-2 [7] . [8] and it was reported that CSF remains positive in HSV-2 infection after completion of acyclovir therapy [9] .
Results

Herpes simplex-characteristic cytopathic effect (prominent plaques, rounded cells) was observed in BHK cells inoculated with patient specimen at 24 hrs after infection confirming the previous results obtained with the Tzanck smear which showed herpes virus family-characteristic multi-nucleated syncytial giant cells (data not shown). DFA with serotype specific antibodies (Remel PathoDx Herpes Typing Kit) at 24 hrs post-inoculation identified the presence of HSV-2 (
Considering the higher seroprevalence of HSV-1 compared to HSV-2 in pregnant women (63% versus 22%) and the population trend of increasing HSV-1 genital infections, determining the herpes serotype is a useful issue not only from an epidemiological standpoint, but also in assessing prognosis and management of potential disseminated infection in neonates and/or disease management of the mother-to-be. (which may include central nervous system (CNS) involvement). Moreover, HSV-2 is less sensitive than HSV-1 to acyclovir
Neonatal HSV infection, which is caused by both HSV-1 and HSV-2 [10, 11] 
, is a severe disease with high mortality and morbidity. While neonate infection with either HSV-1 or HSV-2 is associated with poor prognosis in terms of neurological outcome, in adults
Fig. 3 Forward (F), reverse (R), and probes (P) for generic HSV (UL30), type specific (HSV-1-gD, HSV-2-gG), and DNA extraction control (GFP) used in PCR assay.
Fig. 2A: real-time fluorescence measurements by PCR using the LightCycler instrument (Roche Diagnostics) targeting the UL30 gene of HSV; GFP was used as a DNA extraction control. SNTC= sample negative template control; GFP PC= Green Fluorescent Protein positive control; GFP patient= clinical specimen spiked with GFP; HSV PC= HSV positive control; HSV patient = patient specimen results. (B) real-time fluorescence measurements by PCR using the LightCycler instrument (Roche Diagnostics) targeting the HSV-1 gD and the HSV-2 gG. HSV-1 patient= HSV-1 detected in patient specimen; HSV-2 patient: HSV-2 detected in patient specimen
